Carvacrol-Loaded Nanoemulsion Promotes Tocolytic and Anti-Dysmenorrhea Effects in Rodents
-
Published:2023-12-19
Issue:
Volume:
Page:1-6
-
ISSN:0031-7012
-
Container-title:Pharmacology
-
language:en
-
Short-container-title:Pharmacology
Author:
Mourão Mirla Rossana Nogueira,Macedo Cícero André Ferreira,Ribeiro Tiago Feitosa,Brito Mariana Coelho,Menezes Pedro Modesto Nascimento,de Medeiros Felipe Santana,Ribeiro Fernanda Pires Rodrigues de Almeida,de Lima Julianeli Tolentino,Moura Marigilson Pontes de Siqueira,Souza Fabrício Souza
Abstract
<b><i>Introduction:</i></b> Carvacrol is a phenolic constituent of essential oils that has antinociceptive, anti-inflammatory, and antioxidant activities. <b><i>Method:</i></b> This study aimed to evaluate the in vitro spasmolytic and in vivo anti-dysmenorrhea potential of a nanoemulsion-containing carvacrol (nanoCARV). <b><i>Results:</i></b> In isolated rat uterus, nanoCARV reduced spontaneous contractions (pEC<sub>50</sub> = 3.91 ± 0.25) and relaxed preparations pre-contracted with oxytocin (pEC<sub>50</sub> = 3.78 ± 0.2), carbachol (pEC<sub>50</sub> = 4.15 ± 0.4), prostaglandin F<sub>2α</sub> (pEC<sub>50</sub> = 3.00 ± 0.36), and KCl (pEC<sub>50</sub> = 3.98 ± 0.32). The investigation of the mechanism of action revealed significant differences (<i>p</i> < 0.05) between the pEC<sub>50</sub> values of nanoCARV in the absence or presence of aminophylline or tetraethylammonium. In a primary dysmenorrhea model, treatment with nanoCARV reduced the number of oxytocin-induced abdominal writhes. <b><i>Conclusions:</i></b> These data indicate that the anti-dysmenorrhea effect of nanoCARV may be related to the relaxation of uterine smooth muscle, with participation of the cAMP signaling pathway and potassium channels.
Subject
Pharmacology,General Medicine